VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM
Apr 20, 2017 20:02 pm UTC| Business
TEL AVIV, Israel, April 20, 2017 -- VBL Therapeutics (NASDAQ:VBLT), today announced that the Independent Data Safety Monitoring Committee (DSMC) met to conduct its second safety review of the Phase 3 GLOBE Study...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 20, 2017 20:02 pm UTC| Business
SAN DIEGO, April 20, 2017 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 20, 2017 20:02 pm UTC| Business
SAN DIEGO, April 20, 2017 -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and...
Apr 20, 2017 20:01 pm UTC| Business
EL SEGUNDO, Calif., April 20, 2017 -- Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ:LMRK) announced today that the board of directors of its general partner declared a cash distribution of $0.3525 per...
Apr 20, 2017 20:01 pm UTC| Business
EL SEGUNDO, Calif., April 20, 2017 -- Landmark Infrastructure Partners LP (the “Partnership”) (NASDAQ:LMRK) announced today that the board of directors of its general partner declared a quarterly cash distribution for...
Collegium to Present at the 42nd Annual Deutsche Bank Healthcare Conference
Apr 20, 2017 20:01 pm UTC| Business
CANTON, Mass., April 20, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present at the 42nd Annual Deutsche Bank Healthcare Conference in Boston. The presentation will take place at...
Apr 20, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass., April 20, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Tariff Tremors: Trump’s Greenland Fight Rattles Global Markets